This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Harvard College, Massachusetts Eye and Ear Infirmary, The Ohio State University. Active years: 2026.
Company Filing History:
1 out of 3,071 
1 out of 275 
1 out of 1,575 
Years Active: 2026
Title: Artur Indzhykulian: Innovator in Gene Therapy
Introduction
Artur Indzhykulian is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of gene therapy, particularly in the treatment of hearing loss and blindness. His innovative work has the potential to impact many lives.
Latest Patents
Indzhykulian holds a patent for "AAV vectors encoding mini-PCDH15 and uses thereof." This patent focuses on compositions, nucleic acids, vectors, and viruses that are useful for treating conditions such as Usher Syndrome type IF. The disclosure includes isolated nucleic acids, vectors, and rAAV.9.PHP.B that comprise a transgene encoding a mini-PCDH15. Additionally, it outlines methods for treating hearing loss using these innovations. The patent also provides a gRNA associated with a base editor to correct mutations in PCDH15, which can help in treating hearing and vision loss.
Career Highlights
Throughout his career, Indzhykulian has worked with esteemed institutions such as Harvard College and Massachusetts Eye and Ear Infirmary. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Indzhykulian has collaborated with notable colleagues, including Maryna V Ivanchenko and David P Corey. These partnerships have further enhanced his research and development efforts in gene therapy.
Conclusion
Artur Indzhykulian is a key figure in the advancement of gene therapy, with a focus on treating hearing loss and blindness. His innovative patent and collaborations with leading institutions highlight his commitment to improving healthcare outcomes.